Akgol G, Yildiz C, Karakus S, Koc M, Dogan M, Turan K, Karadayi K
Eur J Gynaecol Oncol. 2016;37(6):781-785.
Intra-abdominal adhesions are a major complication of healing. Furthermore these adhesions may cause morbidity and sometimes mortality for patients, and also are a financial burden to the health system.
Cecum abrasion was performed in all rats and solutions containing saline to group 1, 5-fluorouracil to group 2, cisplatin to group 3, paclitaxel to the group 4, and mitomycin-C were administered into the abdomen of the groups, respectively. The intra-abdominal adhesions were scored after the macroscopic evaluation.
Among the chemotherapeutic drugs, paclitaxel significantly increases occurring of intra-abdominal adhesions in comparison with the control group and the other drugs according to the evaluation of scoring and statistical studies.
It is suggested to use the drugs which have a proven anti-adhesion feature or barriers to the patients who are going to be applied intraperitoneal chemotherapy with paclitaxel.
腹腔内粘连是愈合过程中的主要并发症。此外,这些粘连可能导致患者发病,有时甚至死亡,同时也是卫生系统的经济负担。
对所有大鼠进行盲肠擦伤,分别向第1组腹腔内注入含生理盐水的溶液,向第2组注入5-氟尿嘧啶,向第3组注入顺铂,向第4组注入紫杉醇,向另一组注入丝裂霉素-C。在进行宏观评估后对腹腔内粘连进行评分。
根据评分评估和统计研究,在化疗药物中,与对照组和其他药物相比,紫杉醇显著增加了腹腔内粘连的发生率。
建议对即将接受紫杉醇腹腔化疗的患者使用具有已证实的抗粘连特性的药物或屏障。